Trends in low vision service utilisation: A retrospective study based on general population healthcare claims.
healthcare claims
low vision
low vision services
service utilisation
visual impairment
Journal
Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)
ISSN: 1475-1313
Titre abrégé: Ophthalmic Physiol Opt
Pays: England
ID NLM: 8208839
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
23
02
2022
received:
29
10
2021
accepted:
23
02
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
9
6
2022
Statut:
ppublish
Résumé
To identify parameters associated with the downward trend in the uptake of Low Vision Services (LVS) in the Netherlands. A retrospective cohort study was conducted based on a Dutch national health insurance claims database (Vektis CV) of all adults (≥18 years) who received LVS from 2015 until 2018. Descriptive statistics were used to assess socio-demographic, clinical and contextual characteristics and other healthcare utilisation of the study population. General estimating equations trends in characteristics and healthcare utilisation were determined over time. A total of 49,726 unique patients received LVS, but between 2015 and 2018, the number of patients decreased by 15%. The majority was aged 65 years or older (53%), female (54%), had a middle (38%) or low (24%) socio-economic status and lived in urban areas (68%). Between 2015-2018, significant downward trends were found for treatment with intravitreal injections and lens-related diseases for LVS patients. For physical comorbidity, utilisation of ophthalmic care, low vision aids and occupational therapy, a significant upward trend was found over time. The decrease of Dutch LVS patients by 15% between 2015 and 2018 might be explained by a reduced distribution of patients treated with intravitreal injections and patients with lens-related diseases within the LVS. Compared to 2015, patients were more likely to have physical comorbidity, to see an ophthalmologist and to use low vision aids and occupational therapy in 2016, 2017 and 2018. This might indicate enhanced access to LVS when treated by ophthalmologists or within other medical specialties, or the opposite, i.e., less access when not treated within one of these medical specialties. Future research is needed to examine differences in patterns between LVS users and non-users further.
Identifiants
pubmed: 35661209
doi: 10.1111/opo.12982
pmc: PMC9325458
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
828-838Informations de copyright
© 2022 The Authors. Ophthalmic and Physiological Optics published by John Wiley & Sons Ltd on behalf of College of Optometrists.
Références
J Glaucoma. 2018 Jul;27(7):653-655
pubmed: 29750718
Cochrane Database Syst Rev. 2020 Jan 27;1:CD006543
pubmed: 31985055
Arch Ophthalmol. 2009 May;127(5):681-9
pubmed: 19433720
Ophthalmic Epidemiol. 2020 Aug;27(4):252-258
pubmed: 31985303
BMC Psychiatry. 2017 Aug 1;17(1):280
pubmed: 28764679
Optom Vis Sci. 2015 Mar;92(3):365-74
pubmed: 25599339
Qual Life Res. 2015 Apr;24(4):969-78
pubmed: 25398494
J Cataract Refract Surg. 2021 Mar 1;47(3):373-378
pubmed: 33086294
Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):8933-8
pubmed: 21989722
Haemophilia. 2020 May;26(3):520-528
pubmed: 32268006
Can J Ophthalmol. 2015 Jun;50 Suppl 1:S34-9
pubmed: 26049889
J Bone Miner Res. 2004 Sep;19(9):1539-47
pubmed: 15312256
Neth Heart J. 2018 Jan;26(1):13-20
pubmed: 29119544
Lancet Glob Health. 2021 Feb;9(2):e130-e143
pubmed: 33275950
Eur J Pain. 2017 Apr;21(4):705-715
pubmed: 27860026
Acta Ophthalmol. 2013 Sep;91(6):540-6
pubmed: 23171290
Ophthalmology. 2014 May;121(5):1134-41
pubmed: 24433971
Ophthalmic Physiol Opt. 2003 Jul;23(4):321-7
pubmed: 12828622
Invest Ophthalmol Vis Sci. 2015 Jan 20;56(2):849-54
pubmed: 25604690
Can J Ophthalmol. 2019 Apr;54(2):229-236
pubmed: 30975347
Cancer Med. 2020 Sep;9(18):6888-6895
pubmed: 32710528
J Gerontol B Psychol Sci Soc Sci. 2018 Mar 2;73(3):532-542
pubmed: 26843396
Ophthalmic Physiol Opt. 2022 Jul;42(4):828-838
pubmed: 35661209
JAMA Ophthalmol. 2016 Sep 1;134(9):959-66
pubmed: 27466983
Acta Ophthalmol. 2016 Feb;94(1):76-82
pubmed: 26545339
Ageing Res Rev. 2011 Sep;10(4):430-9
pubmed: 21402176
Eye (Lond). 2020 Feb;34(2):344-351
pubmed: 31388131
Clin Exp Optom. 2016 Nov;99(6):555-558
pubmed: 27320822
Lancet. 2017 Aug 5;390(10094):600-612
pubmed: 28242111
Qual Life Res. 2012 Oct;21(8):1405-11
pubmed: 22090173
Curr Opin Ophthalmol. 2011 Jan;22(1):19-27
pubmed: 21088580
BMJ Open. 2013 Nov 07;3(11):e003471
pubmed: 24202057
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234
pubmed: 29032195
Clin Exp Optom. 2011 Mar;94(2):181-6
pubmed: 21175824
Health Syst Transit. 2016 Mar;18(2):1-240
pubmed: 27467715
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4103-9
pubmed: 19357359